K-Beauty Approved VC-IP Serum: 45% Whitening Efficacy(Clinical Data Inside)
Article Title:
K-Beauty Approved VC-IP Serum: 45% Whitening Efficacy(Clinical Data Inside)
Meta Description:
Blue Eyes Biotech's VC-IP serum active delivers 45%whitening efficacy per Korean clinical trials. KFDA-compliant & vegan.Request clinical reports: [email protected]
VC-IP:The K-Beauty Gold Standard for Radical Brightening
In Seoul'scutting-edge labs, VC-IP (Tetrahexyldecyl Ascorbate) has dethroned traditionalVitamin C as the brightening powerhouse in K-Beauty serums. Blue Eyes Biotech'sclinically validated VC-IP serum concentrate delivers 45% reduction in melaninindex – outperforming L-ascorbic acid by 2.3x in Korean human trials.
Why Korean Brands Choose Our VC-IP:
①DeepEpidermal Penetration
Oil-soluble molecular structure achieves8.7μm dermal delivery depth (vs. 2.1μm for water-based Vitamin C), verifiedthrough confocal Raman spectroscopy at Seoul National University.
②Acid-FreeBrightening
Neutral pH (6.2-6.8) eliminates irritationwhile inhibiting tyrosinase 89% more effectively than 20% ascorbic acidformulations – critical for sensitive Asian skin types.
Clinical Proof from
In a 56-day double-blind study with 32participants at Busan Dermatology Center:
- 45.2% decrease in melanin density(Mexameter® MX18)
- 37.8% improvement in skin evenness(Visia® CR analysis)
- Zero irritation incidents vs. 34% inL-ascorbic acid control group
Formulation Advantages for Global Brands:
- Cold-process compatible (stable up to85°C)
- Synergistic with: Niacinamide, tranexamicacid, rice ferment filtrate
- Vegan & Halal-certified (noanimal-derived squalane)
K-Beauty Compliance Guaranteed:
• Meets KFDAFunctional Cosmetics Standard (brightening category)
•ISO 22716certified manufacturing
•Batch-specific heavy metal reports (<0.1ppm lead/arsenic)
Request Your Clinical Dossier
Access full trial methodology, before/aftervisuals, and formulation guidelines. Contact Blue Eyes Biotech:
